financetom
Business
financetom
/
Business
/
US anti-trust trial in Tapestry bid for Capri ends, judge's decision awaited
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US anti-trust trial in Tapestry bid for Capri ends, judge's decision awaited
Sep 30, 2024 10:56 PM

NEW YORK (Reuters) - The U.S. anti-trust trial over the $8.5 billion bid by luxury goods maker Tapestry to buy Capri concluded on Monday, with Tapestry lawyers citing an "intensely competitive" handbag market in defending against claims that consumers would face higher prices.

At the New York trial, the U.S. Federal Trade Commission sought to prove in its closing arguments that the deal to bring six brands - Tapestry's Coach, Kate Spade, and Stuart Weitzman with Capri's Versace, Jimmy Choo, and Michael Kors - into a single company would leave shoppers with fewer, more expensive handbags than if the companies were separate.

FTC counsel Abby Dennis tried to draw parallels between the multiple transportation methods to get to Washington D.C. from New York - such as buses, trains, planes and even helicopters - but how difficult it is for consumers to interchange between those options because of price limitations. She said Americans face the same challenges with handbags.

A U.S. federal judge will decide whether to block the merger that was announced in August 2023, or allow it to proceed. A decision could be expected anywhere between three weeks to three months, according to Tapestry.

"The judge... has an avalanche of material thrown at her and needs some time to think through it. You cannot say this one is in the bag for either of the parties," said James Weingarten, a former FTC chief trial counsel, who now works in Washington D.C. at law firm Milbank.

Over seven days of evidentiary proceedings, lawyers for both sides spent considerable time focused on defining the so-called "accessible luxury" marketplace. While the FTC relied on an expert witness, economist Loren Smith, to evaluate the market, lawyers for Tapestry poked holes in the financial modeling and methodology used to define the market. Tapestry's lead counsel Lawrence Buterman on Monday requested the judge completely disregard the analysis.

"The FTC can't meet their burden under any standard," Buterman said in closing, asking the judge to allow the merger to proceed.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sonoma Pharmaceuticals Expands Distribution Deal for Wound Care Products to Canada
Sonoma Pharmaceuticals Expands Distribution Deal for Wound Care Products to Canada
Oct 22, 2024
12:04 PM EDT, 10/22/2024 (MT Newswires) -- Sonoma Pharmaceuticals ( SNOA ) said Tuesday it amended its distribution agreement with a healthcare distributor to cover the promotion and distribution of its wound care products in Canada, in addition to the US. The expanded deal also adds over-the-counter wound care products for sale in both the US and Canada, Sonoma added....
Former Abercrombie CEO Mike Jeffries indicted for sex trafficking
Former Abercrombie CEO Mike Jeffries indicted for sex trafficking
Oct 22, 2024
Oct 22 (Reuters) - Mike Jeffries, the former chief executive of Abercrombie & Fitch ( ANF ), has been indicted on sex trafficking and prostitution involving dozens of men. The charges were unveiled on Tuesday, a decade after Jeffries left the retailer he built over 22 years into a popular clothing brand known for sexually charged marketing. Jeffries, his partner...
L'Oreal third quarter sales miss expectations as China buys less
L'Oreal third quarter sales miss expectations as China buys less
Oct 22, 2024
PARIS (Reuters) -French cosmetics giant L'Oreal reported a rise in third quarter sales on Tuesday that missed expectations after low consumer confidence in China sapped demand for beauty products. The company, which owns the Maybelline and Lancome brands, said sales for the three months to the end of September were 10.28 billion euros ($11.11 billion), a 3.4% rise on a...
Why ENDRA Life Sciences (NDRA) Stock Is Up 140%
Why ENDRA Life Sciences (NDRA) Stock Is Up 140%
Oct 22, 2024
ENDRA Life Sciences Inc ( NDRA ) shares are trading higher by 94.6% to 43 cents during Tuesday’s session after the company announced the activation of a post market clinical study of the TAEUS liver system. What To Know: ENDRA Life Sciences ( NDRA ) has announced the launch of a post-market clinical study at LMU University Hospital in Munich....
Copyright 2023-2025 - www.financetom.com All Rights Reserved